Accuray Incorporated (ARAY) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Accuray Incorporated (ARAY) is Moderate Underperform.

The composite score behind that read is -0.30, weighing +1.00 of bullish evidence against -0.44 bearish.

Accuray Incorporated last closed at $0.30, +7.14% on the session.

Against the IVW growth benchmark the position is +6.22% over the forecast window.

The read is built from 12 underlying insights — 1 bullish and 11 bearish.

Agreement across those insights is 92%.

16 graded predictions for ARAY so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Accuray Incorporated in the 11th percentile on return on equity, where 100 is best.

Accuray Incorporated is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $33.56M.

StockMap tracks Accuray Incorporated as the 116th largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite Accuray Incorporated ranks 98th of 133 in the group, against a group median of -0.21.

Other Health Care stocks

Accuray Incorporated (ARAY) — StockMap 2-week forecast & tracked accuracy